Chiesi Deutschland

Chiesi, an international, research-driven biopharmaceutical group, develops and markets innovative medicinal and non-medicinal solutions in three business areas:

- AIR: Products and services related to respiratory diseases, as well as for self-medication, including pharmacy-only medicines and cosmetics;

- RARE: Treatment of patients with rare and very rare diseases;

- CARE: Medicines for transplant recipients.

The company’s purpose is to improve people's quality of life, while acting responsibly towards society and the environment. The company aims to achieve net zero emissions by 2035 (Scope 1-3). These efforts are communicated transparently via the website https://actionoverwords.org/de/ and in our sustainability report (https://www.chiesi.com/en/sustainability/sustainability-report).

The Chiesi Group employs more than 7,000 people in 31 countries worldwide, Chiesi GmbH, based in Hamburg, employs around 400 people across Germany. Chiesi is recognised as a Top Employer by the Top Employers Institute time (https://www.top-employers.com/de/employer/chiesi-gmbh-2/), and a “Great Place to Work” (https://greatplacetowork.de/beste-arbeitgeber/chiesi-gmbh-and-amryt-gmbh).

Career: www.chiesi.de/en/career

Data protection: www.chiesi.de/en/data-privacy--cookies

Imprint:

Chiesi GmbH

Ludwig-Erhard-Str. 34

20459 Hamburg

Tel.: +49 (0)40 897 24-0

Fax: +49 (0)40 897 24-212

info.de(at)chiesi.com

Managing Director:

Leonardo Mallmann

Commercial register entry:

Hamburg County Court HRB 84675

Tax ID No. DE222426963

Competent regulatory authority:

Freie und Hansestadt Hamburg

Behörde für Justiz und Verbraucherschutz

Amt für Verbraucherschutz

Abteilung Pharmaziewesen und Medizinprodukte

Billstraße 80

20539 Hamburg